ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2018
PHARMACOGENETIC TESTING BY POLYMORPHIC MARKERS G1846A (CYP2D6*4) AND C100T (CYP2D6*10) CYP2D6 GENE IN CORONARY HEART DISEASEPATIENTS, TAKING BETA-BLOCKERS IN THE SAKHA REPUBLIC (YAKUTIA)
Introduction. The aim of this study to determine carrier frequencies of polymorphic markers G1846A (CYP2D6*4) and C100T (CYP2D6*10) of the CYP2D6 gene in coronary heart disease (CHD) patients in Russian and Yakut ethnic groups. The association between theadmin…